266 related articles for article (PubMed ID: 38299264)
41. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
42. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
[TBL] [Abstract][Full Text] [Related]
44. Evidence for heightened genetic instability in precancerous spasmolytic polypeptide expressing gastric glands.
Chen J; Zhu C; Wang C; Hu C; Czajkowsky DM; Guo Y; Liu B; Shao Z
J Med Genet; 2020 Jun; 57(6):385-388. PubMed ID: 30877236
[TBL] [Abstract][Full Text] [Related]
45. Risk of gastric cancer in children with Helicobacter pylori infection.
Cam S
Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126
[TBL] [Abstract][Full Text] [Related]
46. Caudal type homeoboxes as a driving force in
Chen HY; Hu Y; Lu NH; Zhu Y
Gut Microbes; 2020 Nov; 12(1):1-12. PubMed ID: 33031021
[TBL] [Abstract][Full Text] [Related]
47. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression.
Asonuma S; Imatani A; Asano N; Oikawa T; Konishi H; Iijima K; Koike T; Ohara S; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G312-22. PubMed ID: 19520737
[TBL] [Abstract][Full Text] [Related]
48. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Lineage Changes in the Gastric Mucosa Following Infection With
Pinzon-Guzman C; Meyer AR; Wise R; Choi E; Muthupalani S; Wang TC; Fox JG; Goldenring JR
J Histochem Cytochem; 2019 Jan; 67(1):53-63. PubMed ID: 29969055
[TBL] [Abstract][Full Text] [Related]
50. Review article: pre-neoplastic states of the gastric mucosa--a practical approach for the perplexed clinician.
Genta RM; Rugge M
Aliment Pharmacol Ther; 2001 Jun; 15 Suppl 1():43-50. PubMed ID: 11488661
[TBL] [Abstract][Full Text] [Related]
51. [Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].
Muller LB; Fagundes RB; Moraes CC; Rampazzo A
Arq Gastroenterol; 2007; 44(2):93-8. PubMed ID: 17962851
[TBL] [Abstract][Full Text] [Related]
52. Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation.
Ierardi E; Francavilla R; Panella C
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):470-5. PubMed ID: 9494859
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
54. Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.
Rentien AL; Lévy M; Copie-Bergman C; Gagniere C; Dupuis J; Le Baleur Y; Belhadj K; Sobhani I; Haioun C; Delchier JC; Amiot A
Dig Liver Dis; 2018 Feb; 50(2):181-188. PubMed ID: 29102522
[TBL] [Abstract][Full Text] [Related]
55. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.
Kuo HY; Chang WL; Yeh YC; Tsai YC; Wu CT; Cheng HC; Yang HB; Lu CC; Sheu BS
Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27220894
[TBL] [Abstract][Full Text] [Related]
56. Genomic single nucleotide polymorphisms in the offspring of gastric cancer patients predispose to spasmolytic polypeptide-expressing metaplasia after H. pylori infection.
Tsai YC; Hsiao WH; Lin SH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
J Biomed Sci; 2015 Feb; 22(1):16. PubMed ID: 25884934
[TBL] [Abstract][Full Text] [Related]
57. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta-analysis.
Zhu F; Zhang X; Li P; Zhu Y
Helicobacter; 2023 Dec; 28(6):e13013. PubMed ID: 37602719
[TBL] [Abstract][Full Text] [Related]
58. Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives.
Kuo HY; Chang WL; Yeh YC; Cheng HC; Tsai YC; Wu CT; Lin SH; Yang HB; Lu CC; Sheu BS
Helicobacter; 2019 Jun; 24(3):e12578. PubMed ID: 30990573
[TBL] [Abstract][Full Text] [Related]
59. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Radyk MD; Burclaff J; Willet SG; Mills JC
Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
[TBL] [Abstract][Full Text] [Related]
60. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
